logo
Green into silver
BJCP 25th anniversary
Drug discovery and development in the molecular era
How will knowledge of the human genome affect drug therapy?
Clinical pharmacology and drug regulation
The use of atypical antipsychotics in the management of schizophrenia
The therapeutic monitoring of antimicrobial agents
Comparison of urinary 6β-hydroxycortisol/cortisol ratio between neonates and their mothers
Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics
Pharmacokinetics of flutamide in patients with renal insufficiency
A study of the relative bioavailability of cysteamine hydrochloride, cysteamine bitartrate and phosphocysteamine in healthy adult male volunteers
The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination
Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers
Differential vascular α1-adrenoceptor antagonism by tamsulosin and terazosin
Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation
The effects of age on human venous responsiveness to neuropeptide Y
Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins
A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP)
Record-linkage for pharmacovigilance in Scotland
Cough and angiotensin II receptor antagonists: cause or confounding?
Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy
CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype